MELISSA MARCOMBE: Open Payments
NPI 1124256706 · GRAY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 11 payments from 6 companies in 2025. Trend: 2023 $471 · 2024 $876 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $265 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $63 |
| Amgen Inc. | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| ABIOMED | 1 | $20 |
| SCPHARMACEUTICALS INC. | 1 | $15 |
Products named: Ozempic, CAPLYTA, REPATHA, LEQVIO, Wegovy, FUROSCIX.
Industry payments across LA — which companies pay providers there.
